✦ LIBER ✦

An FHIT tumor suppressor gene?

✍ Scribed by Michelle M. Le Beau; Harry Drabkin; Thomas W. Glover; Robert Gemmill; Feyruz V. Rassool; Timothy W. McKeithan; David I. Smith

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 80 KB
Volume: 21
Category: Article
ISSN: 1045-2257
DOI: 10.1002/(sici)1098-2264(199804)21:4<281::aid-gcc1>3.0.co;2-v

No coin nor oath required. For personal study only.

✦ Synopsis

3 PERSPECTIVE ARTICLE 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3

📜 SIMILAR VOLUMES

Tumor suppressor genes and breast cancer

✍ Thomas A. Buchholz; Michael M. Weil; Michael D. Story; Eric A. Strom; William A. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 2 views

The genetic determinants for most breast cancer cases remain elusive. However, a mutation in a tumor suppressor gene, such as p53, BRCA1, BRCA2, or ATM, has been determined to be one mechanism of breast carcinogenesis. It has been established that inherited mutations in p53, BRCA1, and BRCA2 signifi

E-cadherin as a tumor (invasion) suppres

E-cadherin as a tumor (invasion) suppressor gene

✍ Walter Birchmeier 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB

Diffuse-type gastric carcinomas show diminished cell-cell adhesion. A recent paper(') reports that 50% of these carcinomas contain mutations in the Ecadherin gene, resulting in the destruction of the calcium-binding sites of Ecadherin, and providing strong in vivo evidence that alterations in E-cadh

Mutations of p53 tumor-suppressor gene i

Mutations of p53 tumor-suppressor gene in angiosarcoma

✍ Norifumi Naka; Yasuhiko Tomita; Hirofumi Nakanishi; Nobuhito Araki; Tadashi Hong 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 50 KB 👁 2 views

Transgenic mice deficient for the p53 gene were reported to frequently develop angiosarcoma (AS), suggesting that alterations in the gene are associated with tumorigenesis of AS. However, little is known about genetic changes, including p53 gene alterations, in human AS because of its rarity. We ana

p53 tumor-suppressor gene: Clues to mole

p53 tumor-suppressor gene: Clues to molecular carcinogenesis

✍ Xin W. Wang; Curtis C. Harris 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views

The tumor-suppressor gene product p53 is clearly a component in several biochemical pathways, including transcription, DNA repair, genomic stability, cell-cycle control and apoptosis, that are central to human carcinogenesis. The p53 is functionally inactivated by mutational, viral, and cellular mec

Role of tumor suppressor genes in transp

Role of tumor suppressor genes in transplacental lung carcinogenesis

✍ Lisa A. Rollins; Sandra Leone-Kabler; M. Gerard O'Sullivan; Mark Steven Miller 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB 👁 2 views

Most human cancers involve multiple genetic changes, including activation of oncogenes such as Ki-ras-2 (Kras2) and inactivation of any one of a number of tumor suppressor genes such as p53 and members of the retinoblastoma (Rb) regulatory axis. As part of an ongoing project to determine how in uter

Use of twins in search for tumor suppres

Use of twins in search for tumor suppressor genes

✍ Asta Försti; Magnus Söderberg; Kari Hemminki 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 3 views

A new approach is applied in the mapping of tumor suppressor genes: analysis of loss of heterozygosity (LOH) in concordant tumors of monozygotic and dizygotic twins. The method relies on recognition of genome locations undergoing loss in both twins in a high proportion of the set of all twin pairs e